We only have this paper's title and publication details.
Read it at the sourceRetraction reveals diazepam's potential to enhance metformin's antidiabetic and anxiolytic effects in type-2 diabetes, indicating issues in findings.
No takes yet. Share an insight, caveat, or question.
BioMed Research International (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: